Recent Breakthroughs in Blood Collection and Storage Are Redefining the Possibilities of Blood Transfusion
Since blood transfusion was first introduced in the 17th century, there have been umpteen efforts to push its boundaries,...
Research Frontiers in Christmas Disease (Hemophilia B): Promising Developments and Future Prospects
Amidst the festive melodies and the aroma of Christmas delights, an intriguing connection quietly resides – Hemophilia B, also...
Hurler syndrome gene therapy shows early success in a small study
Hurler syndrome (also called mucopolysaccharidosis type 1, Hurler variant [MPSIH]), is a genetic disorder that causes abnormal musculoskeletal development,...
Recent Medical Breakthroughs to See a Change in the World
Research in different areas of therapy for various diseases has led to a wide range of treatments. Various diseases...
Recent developments in therapy for HER2+ and HER2- Non-small cell lung cancer
Lung cancer kills more people worldwide than breast, prostate, colorectal, and brain cancers combined.1 Non-small cell lung cancer (NSCLC)...
Ovarian Cancer: The new normal- Standards of care before, during and after the pandemic – Part 1
COVID-19 is a severe acute respiratory syndrome that has blighted the world over the last year. The World Health...
FDA Approves Pradaxa (Dabigatran Etexilate), the First Oral Anticoagulant for Children
The Food and Drug Administration approves Boehringer Ingelheim’s Pradaxa (dabigatran etexilate) oral pellets to treat venous thromboembolism (VTE) in children aged 3...
Avapritinib approved by FDA for use in systemic mastocytosis
On June 16, 2021, the FDA approved a new targeted drug for advanced systemic mastocytosis, a group of rare...
FDA Approves First Trial of CRISPR for Sickle Cell Disease
The U.S Food and Drug Administration (FDA) has approved the first clinical trial of CRISPR to correct sickle cell...